Abstract:Polymer micelles can solubilize hydrophobic drugs and have the effect of improving pharmacokinetics and reducing drug toxicity owing to their unique physical and chemical structure and properties. Temperature-sensitive hydrogels have been applied in drug delivery systems, especially in situ treatment. In this work, dual-sensitive PCL20-PDEA15-ss-PMPC12 micelles were used to encapsulate a hydrophobic photosensitizer (Ce6). Then, the micelles containing Ce6 were embedded into temperature-sensitive F-127 hydrogel where the chemotherapy drug doxorubicin hydrochloride (DOX·HCl) was loaded, in order to prepare dual-sensitive micelle chimeric hydrogel Ce6-micelle/DOX·HCl-G. The results of scanning electron microscope show that the micelles were successfully embedded in the hydrogel and dispersed evenly. Rheometer measurement and tube inversion method prove that Ce6-micelle/DOX·HCl-G is quickly converted from the sol state to the gel state at 37 ℃. The in vitro drug release and erosion behavior of Ce6-micelle/DOX·HCl-G show that the drug release and the hydrogel erosion follow zero-order kinetic characteristics, and the cumulative releases of Ce6 and DOX·HCl are fitted to the gel erosion. The Ce6 in Ce6-micelle/DOX·HCl-G could produce singlet oxygen under 660 nm laser irradiation. Cytotoxicity assays show that the survival rate of 4T1 cancer cells co-cultured with Ce6-micelle/DOX·HCl-G is the lowest among the four irradiated groups, and it is also significantly lower than that without irradiation. In vivo animal experiment shows that the tumor size of Ce6-micelle/DOX·HCl group is less than 1/5 of the tumor size of the blank group after 8 d treatment, when mice are received once at the two sides of tumors and by irradiation with a 660 nm laser at 30 min, 6 h, 24 h, and 48 h after the administrations. Therefore, Ce6-micelle/DOX·HCl-G has the potential to realize the combination of photodynamic therapy and chemotherapy in the treatment of tumors.